The Europe needles market refers to the dynamic industry encompassing the production, distribution, and utilization of various medical needles in European countries. In the healthcare sector, hypodermic needles, injection needles, and blood collection needles are essential for vaccinations, blood sampling, and drug administration. Additionally, the market includes specialized needles for diagnostic and therapeutic procedures. The needle market in the medical sector is crucial for healthcare professionals, ensuring accurate and safe medical interventions globally.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-needles-market
Data Bridge Market Research analyses that the Europe Needles Market is expected to grow at a CAGR of 7.50% in the forecast period of 2023 to 2030 and is expected to reach USD 4,319.33 million by 2030 from USD 2,421.86 million in 2022. The substantial aging population in Europe contributes to an elevated occurrence of chronic illnesses, escalating the need for medical needles in diagnostic and treatment procedures to address the healthcare requirements of elderly individuals.
Key Findings of the Study
Growing rate of product approvals from organizations is expected to drive the market's growth rate
The Europe needles market is experiencing a notable surge in product approvals by authorized bodies. In 2022, Takeda's TAKHZYRO injection single-dose prefilled syringe gained approval from the United States Food and Drug Administration (U.S. FDA) for preventing hereditary angioedema (HAE) attacks. Such approvals signify enhanced safety and efficacy and bolster the demand for needles. This trend is anticipated to be a significant driver in propelling regional market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Conventional Needles and Safety Needles), Product Type (Suture Needles, Blood Collection Needles, Ophthalmic Needles, Dental Needles, Insufflation Needles, Pen Needles and Others), Material (Stainless Steel, Plastic Needles, Glass Needles and Peek Needles), Delivery Mode (Hypodermic Needles, Intravenous Needles, Intramuscular Needles and Intraperitoneal Needles), End Users (Hospitals, Diagnostic Centers, Home Care and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe
|
|
Market Players Covered
|
Medtronic (Ireland), Ethicon U.S., LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novo Nordisk A/S (Denmark), B.D. (U.S.), Stryker (U.S.), Boston Scientific Corporation (U.S.), Luminex Corporation (U.S.), Illumina, Inc (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Netherlands), Abcam plc (U.K.), Merck KGaA (Germany), Promega Corporation (U.S.), Siemens (Germany), PerkinElmer, Inc. (U.S.) and Shimadzu Corporation (Japan)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Europe needles market is segmented on the basis of type, product type, material, delivery mode, end users, and distribution channel.
- On the basis of type, the Europe needles market is segmented into conventional needles and safety needles.
- On the basis of product type, the Europe needles market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and others.
- On the basis of material, the Europe needles market is segmented into stainless steel, plastic needles, glass needles, and peek needles.
- On the basis of delivery mode, the Europe needles market is segmented into hypodermic needles, intravenous needles, intramuscular needles, and intraperitoneal needles.
- On the basis of end users, the Europe needles market is segmented into hospitals, diagnostic centers, home care, and others.
- On the basis of distribution channel, the Europe needles market is segmented into direct tender and retail sales.
Major Players
Data Bridge Market Research recognizes the following companies as the major Europe needles market players in Europe needles market are Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Netherlands), Abcam plc (U.K.), Merck KGaA (Germany), Promega Corporation (U.S.), Siemens (Germany), PerkinElmer, Inc. (U.S.) and Shimadzu Corporation (Japan).
Market Developments
- In 2022, Roche Diabetes Care unveiled its ACCU-FINE pen needles, designed to facilitate painless insulin delivery. This innovative product aims to improve the insulin administration experience, contributing to more effective diabetes management for individuals coping with the condition. With a focus on patient comfort and convenience, Roche's ACCU-FINE pen needles are pivotal in enhancing the overall quality of life for those requiring insulin therapy, making it a valuable addition to the diabetes care landscape.
- In April 2021, B. Braun Melsungen AG achieved recognition by winning the IF DESIGN AWARD 2021 in the Health/Medical category, earning approval from a prestigious 98-member jury. The award, organized and sponsored by IF International Forum Design GmbH, significantly elevated the company's reputation and profile. This accolade acted as a powerful catalyst, attracting a larger customer base and driving increased profitability in the market for B. Braun Melsungen AG.
- In February 2021, Thermo Fisher Scientific celebrated a significant achievement, winning six awards in the prestigious CMO Leadership Awards hosted by Life Science Leader and Outsourced Pharma. These accolades, bestowed by biopharma and biotech companies, affirm Thermo Fisher's excellence in contract manufacturing. The recognition bolstered the company's global presence and is also anticipated to propel its growth in the years ahead. Thermo Fisher's exceptional performance is poised to lead to a substantial upswing in the company's market influence and expansion.
- In June 2020, B. Braun Melsungen AG celebrated a remarkable achievement as its subsidiary, Aesculap, secured five consecutive awards at the Red Dot Design Award 2020. The accolades were bestowed upon their latest products, including the Container system, OrthoPilot, and Multitool. This recognition significantly elevated the company's profile and global standing, increasing customer attention worldwide. B. Braun's commitment to innovative design was affirmed, solidifying its reputation as a leader in the industry.
Regional Analysis
Geographically, the countries covered in the Europe needles market report are
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
As per Data Bridge Market Research analysis:
Germany is estimated to be the fastest-growing region in Europe needles market for the forecast period 2023 - 2030
Germany is poised for significant growth in the forecast period, driven by a rising prevalence of chronic diseases and extensive research endeavors. The increasing sedentary lifestyle, coupled with the need for various injection medications, further fuels this expansion. Moreover, Germany's substantial elderly and vulnerable populations contribute to the market's growth prospects. These factors collectively establish a compelling case for Germany's healthcare industry to exhibit the highest compound annual growth rate (CAGR) in the coming years.
For more detailed information about the Europe needles market report, click here – https://www.databridgemarketresearch.com/reports/europe-needles-market
